Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck forges ahead with phase 3 trial of Humira biosimilar
Merck forges ahead with phase 3 trial of Humira biosimilar
Merck forges ahead with phase 3 trial of Humira biosimilar
Submitted by
admin
on March 4, 2016 - 2:00pm
Source:
BioPharma Dive
News Tags:
Merck
Humira
biosimilar
MSB11022
AbbVie
psoriasis
Headline:
Merck forges ahead with phase 3 trial of Humira biosimilar
Do Not Allow Advertisers to Use My Personal information
